𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia

✍ Scribed by Lin, T-C; Hou, H-A; Chou, W-C; Ou, D-L; Yu, S-L; Tien, H-F; Lin, L-I


Book ID
109887252
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
406 KB
Volume
25
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic value of immunophenotyping in
✍ Claudiu Plesa; Youcef Chelghoum; Adriana Plesa; Mohamed Elhamri; Isabelle Tigaud πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The poor prognosis for elderly patients with acute myeloid leukemia (AML) raises questions regarding the benefit of treating them with intensive chemotherapy. The impact of initial characteristics on prognosis has been addressed previously in elderly patients; however, v